Xconomy: Robotics and A.I.

National
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More

National
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More
National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More

1.
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System | New York
2.
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies | San Francisco
3.
Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs | Texas
4.
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More | National
5.
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA | National
6.
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More | National

Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More
Frank Vinluan | National
AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
Jeff Bauter Engel | Wisconsin
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund
Gareth Macdonald | National
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
Frank Vinluan | National
Nuance & Microsoft Team Up on Conversational AI for Doctors’ Offices
Jeff Bauter Engel | Boston
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
Bernadette Tansey | San Francisco
High-Flying Ginkgo Nets Another $290M to Program Cells Like Computers
Frank Vinluan | Boston
WI Watchlist: Epic, Frontdesk, Shine, StartingBlock Madison & More
Jeff Bauter Engel | Wisconsin
ThoughtSpot Nabs $248M for Accessible Analytics, Nears $2B Valuation
Bernadette Tansey | San Francisco

Read More Posts ›

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Xconomy on Demand

We offer a number of ways to subscribe for free!